vimarsana.com

Latest Breaking News On - Simple endoscopic score - Page 1 : vimarsana.com

Redefining IBD Care: Intestinal Ultrasound's Emerging Role in Treat-to-Target Strategies

In honor of World Digestive Health Day, this feature examines the growth of intestinal ultrasound in IBD care in the US and how it aligns with STRIDE-II guidance.

Calgary
Alberta
Canada
University-of-chicago
Illinois
United-states
Chicago
Michael-dolinger
Marla-dubinsky
Noa-krugliak-cleveland
Krugliak-cleveland
Appropves-risankizumab

Mirikizumab Shows Promise for Moderate to Severe Crohn's

Already approved for ulcerative colitis, the monoclonal antibody mirikizumab met study endpoints for Crohn's disease response and remission.

Washington
District-of-columbia
United-states
New-york
Brucee-sands
Eli-lilly
Icahn-school-of-medicine-at-mount-sinai
Langone-health
Inflammatory-bowel-disease-center
Icahn-school
Mount-sinai
Digestive-disease-week

Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024

-Enrollment continued on target in EMERALD-2 Phase 2b trial of MORF-057 in ulcerative colitis-

Simon-cooper
Chris-erdman
Praveen-tipirneni
Key-additions-to-morphic-leadership-team
Development-program
Napp-pharmaceutical-research
Exchange-commission
University-of-newcastle-upon-tyne-medical-school
Morphic-holding-inc
Wyeth-research
Human-genome-sciences
Kadmon-holdings

Upadacitinib Provides Rapid Relief in Crohn's Disease

Patients with Crohn's disease achieved rapid symptom relief with upadacitinib, including those with prior biologic failure.

New-york
United-states
Icahn-school-of-medicine-at-mount-sinai
Department-of-medicine
Simple-endoscopic-score
Icahn-school
Mount-sinai
New-york-city
Clinical-gastroenterology
Crohn-amp-039s-disease
Crohn-disease

Bristol Myers Squibb Provides Update on the First Phase 3 YELLOWSTONE Trial Evaluating Oral Zeposia (ozanimod) in Patients with Moderate to Severe Active Crohn's Disease -March 28, 2024 at 04:02 pm EDT

Bristol Myers Squibb today announced an update following the initial analysis of results from the first of two induction studies in the Phase 3 YELLOWSTONE clinical trial program evaluating Zeposia .

Roland-chen
Bristol-myers-squibb
Facebook
Twitter
Exchange-commission
Clinical-trial-program
Youtube
Instagram
Linkedin
Bristol-myers
Disease-activity-index
Simple-endoscopic-score

vimarsana © 2020. All Rights Reserved.